Volume 5, Issue 3, Pages (December 1998)

Slides:



Advertisements
Similar presentations
Cytokine Responses to CPB Seoul National University Hospital Department of Thoracic & Cardiovascular Surgery.
Advertisements

Statins as Protective Agents for Aortic Endothelial Cells Robert Kreisberg West Liberty State College.
Atherosclerosis Mike Clark, M.D.. Terms Arteriosclerosis – hardening of the arteries Atherosclerosis – a form of arteriosclerosis Venosclerosis Arteriolosclerosis.
PBL CV 2 Pathophysiology of coronary artery disease.
A Role for Dystroglycan in Basement Membrane Assembly Michael D Henry, Kevin P Campbell Cell Volume 95, Issue 6, Pages (December 1998) DOI: /S (00)
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
03/06/231 K June /06/232 Atherosclerosis Etiology Classic Risk Factors Dyslipidemia Low HDL Epidemiological Studies (e.g. Framingham) Genetic.
Atherosclerosis CVS lecture 2 Atherosclerosis Shaesta Naseem.
atherosclerosis Jon Yap John A. Burns School of Medicine
Atherosclerosis CVS lecture 2 Atherosclerosis. Vessel wall structure.
Dr.Hesham Rashid, MD PATHOGENIC MECHANISMS OF ATHEROSCLEROSIS
Controversial Pathophysiologic Contributors to Acute MI and Atherosclerosis Atherothrombotic events occur in individuals without readily apparent risk.
Is atherosclerosis a metabolic disease?
Chapter 6 The disease of cardiovascular system
Prevention of ischemia-reperfusion injury in cardiac surgery: Therapeutic strategies targeting signaling pathways  Kay Maeda, MD, PhD, Marc Ruel, MD,
Volume 17, Issue 5, Pages (May 2013)
Ischemic cardiovascular involvement in psoriasis: A systematic review
Leukocyte-endothelial cell interactions: Molecular mechanisms and implications in gastrointestinal disease  Julián panés*, D.Neil Granger‡  Gastroenterology 
Endothelins and inflammation: the gastrointestinal system
Volume 61, Issue 6, Pages (June 2002)
Volume 18, Issue 2, Pages (April 2011)
Microvascular responses to sepsis: clinical significance
Tumor necrosis factor: Biology and therapeutic inhibitors
Figure 1 Innate immune responses in atherosclerosis
Ischemic cardiovascular involvement in psoriasis: A systematic review
Craig H Selzman, MD, Stephanie A Miller, MD, Alden H Harken, MD 
Patrick Phelan, MD, Heather E
D. Neil Granger, Peter R. Kvietys  Pathophysiology 
Fig 6.1 Drug released by diffusion
Signalling pathways in alcohol-induced liver inflammation
I. Carmona, P. Cordero, J. Ampuero, A. Rojas, M. Romero-Gómez 
Hans-Joachim Anders, Volker Vielhauer, Detlef Schlöndorff 
The impact of cold ischemia time on renal transplant outcome
Figure 3 Biologics that attenuate effector responses in the kidney
Volume 23, Issue 4, Pages (December 2016)
Peter Celec, Yoshikazu Yonemitsu  Pathophysiology 
Obesity, Inflammation, and Insulin Resistance
Diabetes and atherosclerosis
Inflammatory health effects of indoor and outdoor particulate matter
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions  Batya B. Davidovici, Naveed Sattar,
Editorial II British Journal of Anaesthesia
Thrombosis and Inflammatory Bowel Disease
Lipid core constitution Activated macrophages accumulate lipids
F. Berenbaum  Osteoarthritis and Cartilage 
Endothelial Cell Injury in Cardiovascular Surgery: The Systemic Inflammatory Response1  Edward M Boyle, MD, Timothy H Pohlman, MD, Marion C Johnson, MD,
Karel J. van Erpecum, Frank G. Schaap  Journal of Hepatology 
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Correction Journal of Vascular Surgery
Negative Feedback Mechanisms and Their Roles during Pattern Formation
Diarmaid Dominic Houlihan, Philip Noel Newsome  Gastroenterology 
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Monocyte-Macrophages and T Cells in Atherosclerosis
Anti-Cytokine Therapies in Response to Systemic Infection
Endothelial cell activation
Benjamin Lockshin, MD, Yevgeniy Balagula, MD, Joseph F
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
The Biological Role of Inflammation in Atherosclerosis
Chemokines: Key Players in Innate and Adaptive Immunity
Macrophages in the Pathogenesis of Atherosclerosis
Do Oxidized Lipoproteins Cause Atherosclerotic Cardiovascular Diseases?  Benoit J. Arsenault, PhD, Raphaëlle Bourgeois, MSc, Patrick Mathieu, MD, MSc,
Role of immunocompetent cells in nonimmune renal diseases
Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription  Edward M Boyle, MD, Timothy G Canty, MD, Elizabeth N Morgan,
Chemokines and allergic disease
Impaired Lung Function and Risk for Stroke
James K Kirklin, MD, David C McGiffin, MD 
Atherosclerosis  Christopher K. Glass, Joseph L. Witztum  Cell 
Endothelial Cell Injury in Cardiovascular Surgery
Tumor necrosis factor: Biology and therapeutic inhibitors
Edward M. Boyle, Timothy H. Pohlman, Carol J. Cornejo, Edward D
NF-κB, Inflammation, and Metabolic Disease
Presentation transcript:

Volume 5, Issue 3, Pages 167-184 (December 1998) The role of leukocyte-endothelial cell adhesion in cardiovascular disease  Michael J. Eppihimer  Pathophysiology  Volume 5, Issue 3, Pages 167-184 (December 1998) DOI: 10.1016/S0928-4680(98)00023-6

Fig. 1 Mechanism proposed to explain the accumulation of leukocytes in myocardial tissue exposed to ischemia and reperfusion. Elevation in ROMs, inflammatory mediators and complement activation induces an elevation in leukocyte and endothelial cell adhesion molecules, and consequently, an increase in leukocyte adhesion and emigration and tissue injury. Pathophysiology 1998 5, 167-184DOI: (10.1016/S0928-4680(98)00023-6)

Fig. 2 Mechanism proposed to explain the accumulation of leukocytes in cerebral tissue exposed to ischemia and reperfusion. Elevation in ROMs, which is potentiated by NO, and inflammatory mediators induces an elevation in leukocyte and endothelial cell adhesion molecules, and consequently, an increase in leukocyte adhesion and emigration and tissue injury. Pathophysiology 1998 5, 167-184DOI: (10.1016/S0928-4680(98)00023-6)

Fig. 3 Mechanism proposed to explain the accumulation of leukocytes in atherosclerotic lesions. Elevation in ox-LDLs produces a concomitant reduction in NO. This is paralleled by an increase in ROMs and other inflammatory mediators. A subsequent increase in leukocyte and endothelial cell adhesion molecules leads to an increase in leukocyte adhesion and emigration. The release of inflammatory mediators from emigrated leukocytes produces a chemotactic signal, which amplifies the magnitude of leukocyte adhesion and emigration. The differentiation of monocytes into macrophages, and their uptake of cholesterol produces the formation of foam cells. In addition to foam cells, growth factors released by emigrated leukocytes induce cell proliferation and consequently, the development of an atherosclerotic lesion. Pathophysiology 1998 5, 167-184DOI: (10.1016/S0928-4680(98)00023-6)